Francisco Pasquel
Overview
Explore the profile of Francisco Pasquel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gujral U, Vanasse L, Goyal A, Quyyumi A, Ayers C, Das S, et al.
BMJ Open
. 2024 Dec;
14(12):e084087.
PMID: 39632106
Objective: To examine inpatient COVID-19-related outcomes among patients with and without diabetes alone or with a history of established heart failure (HF) or established atherosclerotic cardiovascular disease (ASCVD). Design: Observational...
2.
Lopez-Huamanrayme E, Cordova-Huancas C, Garate-Chirinos D, Espinoza-Morales F, Pasquel F
J Diabetes Investig
. 2021 Nov;
13(4):746-748.
PMID: 34816631
No abstract available.
3.
Migdal A, Fortin-Leung C, Pasquel F, Wang H, Peng L, Umpierrez G
J Hosp Med
. 2021 Jul;
16(8):462-468.
PMID: 34328842
Objective: Despite clinical guideline recommendations, sliding scale insulin (SSI) is widely used for the hospital management of patients with type 2 diabetes (T2D). We aimed to determine which patients with...
4.
Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al.
Diabetes Care
. 2015 Jul;
38(9):1665-72.
PMID: 26180108
Objective: The optimal level of glycemic control needed to improve outcomes in cardiac surgery patients remains controversial. Research Design And Methods: We randomized patients with diabetes (n = 152) and...
5.
Bueno E, Benitez A, Rufinelli J, Figueredo R, Alsina S, Ojeda A, et al.
Endocr Pract
. 2015 Jun;
21(7):807-13.
PMID: 26121460
Objective: Few randomized studies have focused on the optimal management of non-intensive care unit patients with type 2 diabetes in Latin America. We compared the safety and efficacy of a...
6.
Umpierrez G, Reyes D, Smiley D, Hermayer K, Khan A, Olson D, et al.
Diabetes Care
. 2014 Aug;
37(11):2934-9.
PMID: 25168125
Objective: Effective treatment algorithms are needed to guide diabetes care at hospital discharge in general medicine and surgery patients with type 2 diabetes. Research Design And Methods: This was a...
7.
Umpierrez G, Gianchandani R, Smiley D, Jacobs S, Wesorick D, Newton C, et al.
Diabetes Care
. 2013 Jul;
36(11):3430-5.
PMID: 23877988
Objective: This study investigated the safety and efficacy of sitagliptin (Januvia) for the inpatient management of type 2 diabetes (T2D) in general medicine and surgery patients. Research Design And Methods:...
8.
Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al.
J Diabetes Sci Technol
. 2012 Oct;
6(5):1022-9.
PMID: 23063027
Objective: We aimed to determine risk factors associated with hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. Methods: We conducted an analysis of three randomized...
9.
Beck Jr G, Khazai N, Bouloux G, Camalier C, Lin Y, Garneys L, et al.
Transl Res
. 2012 Oct;
161(3):145-55.
PMID: 23022285
Thiazolidinedione (TZD) therapy has been associated with an increased risk of bone fractures. Studies in rodents have led to a model in which decreased bone quality in response to TZDs...
10.
Stark R, Pasquel F, Turcu A, Pongratz R, Roden M, Cline G, et al.
J Biol Chem
. 2009 Jul;
284(39):26578-90.
PMID: 19635791
Pancreatic beta-cells couple the oxidation of glucose to the secretion of insulin. Apart from the canonical K(ATP)-dependent glucose-stimulated insulin secretion (GSIS), there are important K(ATP)-independent mechanisms involving both anaplerosis and...